Quent Capital, LLC

Position in ZTS — Zoetis Inc.

CIK 1912338 NEW YORK, NY

Position in ZTS

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$51,539

-$31,753 QoQ

Shares Held

436

-34.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Quent Capital, LLC holds $2,626,931 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	4,123	$2,444,856
2	ZTS	Zoetis Inc. This page	436	$51,539
3	VTRS	Viatris Inc	3,229	$43,623
4	NBIX	Neurocrine Biosciences Inc	188	$24,767
5	ALKS	Alkermes plc.	678	$23,974
6	HIMS	Hims & Hers Health, Inc.	491	$10,193
7	INCR	Intercure Ltd.	10,321	$7,751
8	ELAN	Elanco Animal Health Inc	299	$7,155

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$51,539	436	-34.1%	Shares	Sole	2026-04-28
2025-12-31	$83,292	662	-47.3%	Shares	Sole	2026-01-29
2025-09-30	$183,777	1,256	-0.4%	Shares	Sole	2025-10-27
2025-03-31	$207,623	1,261	-25.5%	Shares	Sole	2025-04-04
2024-12-31	$275,840	1,693	-2.0%	Shares	Sole	2025-01-29
2024-09-30	$337,616	1,728	-1.8%	Shares	Sole	2024-10-04
2024-06-30	$305,113	1,760	+3.0%	Shares	Sole	2024-07-08
2024-03-31	$289,179	1,709	0.0%	Shares	Sole	2024-06-28
2023-12-31	$337,305	1,709	-1.8%	Shares	Sole	2024-06-17
2023-09-30	$302,725	1,740	+12.3%	Shares	Sole	2024-06-17
2023-06-30	$266,753	1,549	+2.1%	Shares	Sole	2024-06-17
2023-03-31	$252,489	1,517	+10.4%	Shares	Sole	2024-06-17
2022-12-31	$201,359	1,374	-5.0%	Shares	Sole	2023-01-19
2022-09-30	$214,575	1,447	+8.2%	Shares	Sole	2022-11-10
2022-06-30	$229,816	1,337	+10.0%	Shares	Sole	2022-08-08
2022-03-31	$229,136	1,215	-53.9%	Shares	Sole	2022-05-12
2021-12-31	$643,263	2,636	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.